BS

Barbra Johnson SASU

CE Cellectis: 2 patents #7 of 19Top 40%
AT Allogene Therapeutics: 1 patents #1 of 7Top 15%
Overall (2021): #178,346 of 548,734Top 35%
2
Patents 2021

Issued Patents 2021

Patent #TitleCo-InventorsDate
11072644 Inhibitory chimeric antigen receptors Arvind Rajpal, Shobha Potluri, Laurent POIROT, Alexandre Juillerat, Thomas Charles PERTEL +1 more 2021-07-27
11014989 Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy Julianne Smith, Julien Valton, Alexandre Juillerat, Philippe Duchateau, Arvind Rajpal 2021-05-25